← Back to headlines
Oncolytics Biotech Concludes Enrollment for GIT Cancer Trial
Oncolytics Biotech has announced the conclusion of enrollments for its clinical trial targeting gastrointestinal (GIT) cancer, leading to gains for the company.
24 Feb, 19:45 — 24 Feb, 19:45
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
India to Launch HPV Vaccination Drive for 14-Year-Old Girls
28m ago
Disabled Woman Forcibly Moved to Nursing Home Against Her Will
37m ago
‘What are the normal, prediabetic, and diabetic ranges for HbA1c, and how do they relate to daily blood sugar levels?’
48m ago
Neurologist Discusses New Migraine Treatments
49m ago